AR125204A1 - Compuestos de lípidos de cola ramificada y composiciones para la administración intracelular de agentes terapéuticos - Google Patents
Compuestos de lípidos de cola ramificada y composiciones para la administración intracelular de agentes terapéuticosInfo
- Publication number
- AR125204A1 AR125204A1 ARP220100685A ARP220100685A AR125204A1 AR 125204 A1 AR125204 A1 AR 125204A1 AR P220100685 A ARP220100685 A AR P220100685A AR P220100685 A ARP220100685 A AR P220100685A AR 125204 A1 AR125204 A1 AR 125204A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkenyl
- alkyl
- independently selected
- group
- carbocycle
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/23—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
- C07C311/24—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/35—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/36—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/35—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/38—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a carbon atom of an acyclic unsaturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/35—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/40—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C233/58—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/78—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/10—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C311/05—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/04—1,2,3-Oxadiazoles; Hydrogenated 1,2,3-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/44—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing eight carbon atoms
Abstract
La descripción presenta composiciones y lípidos nuevos que involucran a los mismos. Las nanopartículas de lípidos (p. ej., LNP vacías o LNP cargadas) incluyen un lípido nuevo y lípidos adicionales como fosfolípidos, lípidos estructurales y lípidos PEG. Las nanopartículas de lípidos (p. ej., LNP vacías o LNP cargadas) que incluyen además productos terapéuticos y/o profilácticos como el ARN son útiles en la administración de productos terapéuticos y/o profilácticos a células u órganos de mamíferos para, por ejemplo, regular la expresión de polipéptidos, proteínas o genes. Reivindicación 1: Un lípido de fórmula (I-1) o su N-óxido, o una sal o isómero del mismo, en donde Rᵃ es: un compuesto de fórmula (2) y Rᵇ es: un compuesto de fórmula (3) o (4); en donde ⁻⁻⁻⁻⁻|⁻⁻⁻⁻⁻ denota un punto de unión; Rᵃᵇ, Rᵃᵍ y Rᵃᵈ se seleccionan cada uno independientemente del grupo que consiste en H, alquilo C₁₋₁₂ y alquenilo C₂₋₁₂, en donde al menos uno de Rᵃᵇ, Rᵃᵍ y Rᵃᵈ se selecciona del grupo que consiste en alquilo C₁₋₁₂ y alquenilo C₂₋₁₂; Rᵇᵇ, Rᵇᵍ y Rᵇᵈ se seleccionan cada uno independientemente del grupo que consiste en H, alquilo C₁₋₁₂ y alquenilo C₂₋₁₂, en donde al menos uno de Rᵇᵇ, Rᵇᵍ y Rᵇᵈ se selecciona del grupo que consiste en alquilo C₁₋₁₂ y alquenilo C₂₋₁₂; cada uno de R² y R³ se selecciona independientemente del grupo que consiste en alquilo C₁₋₁₄ y alquenilo C₂₋₁₄; R⁴ se selecciona de -(CH₂)ₙNRTQ, -(CH₂)ₙNRS(O)₂TQ, -(CH₂)ₙNRC(O)H y -(CH₂)ₙNRC(O)TQ en donde n se selecciona de 1, 2, 3, 4, y 5; T es un enlace o un enlazador de alquilo C₁₋₃, enlazador de alquenilo C₂₋₃ o enlazador de alquinilo C₂₋₃; Q se selecciona de un heterociclo de 3 - 14 miembros que contiene de 1 - 5 heteroátomos seleccionados de N, O y S, carbociclo C₃₋₁₀, alquilo C₁₋₆, alcoxi C₁₋₆ y alquenilo C₂₋₆, en donde el alquilo, alcoxi, alquenilo, heterociclo, y carbociclo están cada uno opcionalmente sustituidos con uno o más RQ; cada RQ se selecciona independientemente del grupo que consiste en oxo, hidroxilo, ciano, amino, alquilamino C₁₋₆, di-alquilamino C₁₋₆, alquilo C₁₋₆, alcoxi C₁₋₆, alquenilo C₂₋₆, alcanolilo C₁₋₆, carbociclo C₃₋₁₀, -C(O)alquilo C₁₋₆ y -NRC(O)alquilo C₁₋₆; cada R se selecciona independientemente de H, alquilo C₁₋₆ y alquenilo C₂₋₆; cada R se selecciona independientemente de alquilo C₁₋₁₂ y alquenilo C₂₋₁₂; m se selecciona de 1, 2, 3, 4, 5, 6, 7, 8 y 9; y l se selecciona de 1, 2, 3, 4, 5, 6, 7, 8 y 9. Reivindicación 2: Un lípido de fórmula (1) o su N-óxido, o una sal o isómero del mismo, en donde Rᵃ es: un compuesto de fórmula (5) y Rᵇ es: un compuesto de fórmula (3) o (6); en donde ⁻⁻⁻⁻⁻|⁻⁻⁻⁻⁻ denota un punto de unión; Rᵃᵍ y Rᵇᵍ son cada uno independientemente alquilo C₁₋₁₂ o alquenilo C₁₋₁₂; cada uno de R² y R³ se selecciona independientemente del grupo que consiste en alquilo C₁₋₁₄ y alquenilo C₂₋₁₄; R⁴ se selecciona de -(CH₂)ₙNRTQ, -(CH₂)ₙNRS(O)₂TQ, -(CH₂)ₙNRC(O)H y -(CH₂)ₙNRC(O)TQ en donde n se selecciona de 1, 2, 3, 4, y 5; T es un enlace o un enlazador de alquilo C₁₋₃, enlazador de alquenilo C₂₋₃ o enlazador de alquinilo C₂₋₃; Q se selecciona de un heterociclo de 3 - 14 miembros que contiene de 1 - 5 heteroátomos seleccionados de N, O y S, carbociclo C₃₋₁₀, alquilo C₁₋₆, alcoxi C₁₋₆ y alquenilo C₂₋₆, en donde el alquilo, alcoxi, alquenilo, heterociclo, y carbociclo están cada uno opcionalmente sustituidos con uno o más RQ; cada RQ se selecciona independientemente del grupo que consiste en oxo, hidroxilo, ciano, amino, alquilamino C₁₋₆, di-alquilamino C₁₋₆, alquilo C₁₋₆, alcoxi C₁₋₆, alquenilo C₂₋₆, alcanolilo C₁₋₆, carbociclo C₃₋₁₀, -C(O)alquilo C₁₋₆ y -NRC(O)alquilo C₁₋₆; cada R se selecciona independientemente de H, alquilo C₁₋₆ y alquenilo C₂₋₆; cada R se selecciona independientemente de alquilo C₁₋₁₂ y alquenilo C₂₋₁₂; m se selecciona de 3, 4, 5, 6 y 7; y l se selecciona de 3, 4, 5, 6 y 7.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202163165724P | 2021-03-24 | 2021-03-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR125204A1 true AR125204A1 (es) | 2023-06-21 |
Family
ID=81308437
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP220100685A AR125204A1 (es) | 2021-03-24 | 2022-03-23 | Compuestos de lípidos de cola ramificada y composiciones para la administración intracelular de agentes terapéuticos |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP4313938A1 (es) |
JP (1) | JP2024512576A (es) |
CN (1) | CN117377653A (es) |
AR (1) | AR125204A1 (es) |
AU (1) | AU2022245247A1 (es) |
CA (1) | CA3214481A1 (es) |
TW (1) | TW202300173A (es) |
WO (1) | WO2022204288A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2022548304A (ja) | 2019-09-19 | 2022-11-17 | モデルナティエックス インコーポレイテッド | 治療薬の細胞内送達のための分岐状尾部脂質化合物及び組成物 |
WO2023154818A1 (en) | 2022-02-09 | 2023-08-17 | Modernatx, Inc. | Mucosal administration methods and formulations |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013086373A1 (en) * | 2011-12-07 | 2013-06-13 | Alnylam Pharmaceuticals, Inc. | Lipids for the delivery of active agents |
SI3766916T1 (sl) * | 2014-06-25 | 2023-01-31 | Acuitas Therapeutics Inc. | Formulacije novih lipidov in lipidnih nanodelcev za dostavo nukleinskih kislin |
US20180256750A1 (en) | 2015-09-17 | 2018-09-13 | Moderna Therapeutics, Inc. | Polynucleotides containing a stabilizing tail region |
WO2017062513A1 (en) | 2015-10-05 | 2017-04-13 | Modernatx, Inc. | Methods for therapeutic administration of messenger ribonucleic acid drugs |
BR112019008481A2 (pt) * | 2016-10-26 | 2020-03-03 | Curevac Ag | Vacinas de mrna de nanopartículas lipídicas |
EP3532103A1 (en) * | 2016-10-26 | 2019-09-04 | Acuitas Therapeutics, Inc. | Lipid nanoparticle formulations |
HUE060693T2 (hu) * | 2017-03-15 | 2023-04-28 | Modernatx Inc | Vegyület és készítmények terápiás szerek intracelluláris bejuttatására |
CN110799492B (zh) * | 2017-04-28 | 2023-06-27 | 爱康泰生治疗公司 | 用于递送核酸的新型羰基脂质和脂质纳米颗粒制剂 |
EP3668833A1 (en) * | 2017-08-16 | 2020-06-24 | Acuitas Therapeutics, Inc. | Lipids for use in lipid nanoparticle formulations |
WO2019036030A1 (en) * | 2017-08-17 | 2019-02-21 | Acuitas Therapeutics, Inc. | LIPIDS FOR USE IN LIPID NANOPARTICLE FORMULATIONS |
CA3128215A1 (en) | 2019-01-31 | 2020-08-06 | Modernatx, Inc. | Methods of preparing lipid nanoparticles |
JP2022548304A (ja) * | 2019-09-19 | 2022-11-17 | モデルナティエックス インコーポレイテッド | 治療薬の細胞内送達のための分岐状尾部脂質化合物及び組成物 |
AU2020351225A1 (en) * | 2019-09-19 | 2022-04-07 | Modernatx, Inc. | Headgroup lipid compounds and compositions for intracellular delivery of therapeutic agents |
BR112022020203A2 (pt) * | 2020-04-09 | 2022-11-22 | Suzhou Abogen Biosciences Co Ltd | Composição de nanopartículas lipídicas |
-
2022
- 2022-03-23 AU AU2022245247A patent/AU2022245247A1/en active Pending
- 2022-03-23 EP EP22716644.4A patent/EP4313938A1/en active Pending
- 2022-03-23 AR ARP220100685A patent/AR125204A1/es unknown
- 2022-03-23 CA CA3214481A patent/CA3214481A1/en active Pending
- 2022-03-23 CN CN202280037716.1A patent/CN117377653A/zh active Pending
- 2022-03-23 JP JP2023558590A patent/JP2024512576A/ja active Pending
- 2022-03-23 WO PCT/US2022/021560 patent/WO2022204288A1/en active Application Filing
- 2022-03-24 TW TW111111204A patent/TW202300173A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
TW202300173A (zh) | 2023-01-01 |
JP2024512576A (ja) | 2024-03-19 |
WO2022204288A1 (en) | 2022-09-29 |
CN117377653A (zh) | 2024-01-09 |
AU2022245247A1 (en) | 2023-10-05 |
CA3214481A1 (en) | 2022-09-29 |
EP4313938A1 (en) | 2024-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR125204A1 (es) | Compuestos de lípidos de cola ramificada y composiciones para la administración intracelular de agentes terapéuticos | |
BR112022004771A2 (pt) | Compostos e composições de lipídio de grupo de cabeça para entrega intracelular de agentes terapêuticos | |
AU2010279299B2 (en) | Lipidated oxoadenine derivatives | |
MX2019011004A (es) | Compuestos y composiciones para la administracion intracelular de agentes terapeuticos. | |
AR120080A1 (es) | Compuestos lipídicos de cola ramificada y composiciones para la administración intracelular de agentes terapéuticos | |
US9708628B2 (en) | Cationic lipid having improved intracellular kinetics | |
MX2022003285A (es) | Compuestos lipidos que contienen carbonato y composiciones para suministro intracelular de agentes terapeuticos. | |
PE20210655A1 (es) | Carbamoil ciclohexil acidos ligados a n de triazol como antagonistas de lpa | |
ES2948971T3 (es) | Lípido catiónico | |
HRP20220652T1 (hr) | Pripravci i postupci unosa terapijskih sredstava | |
ES2926075T3 (es) | Lípido catiónico | |
NO327487B1 (no) | Kationisk liposom samt anvendelse derav | |
US11345738B2 (en) | Compounds for treating neurodegenerative proteinopathies | |
ES2859923T3 (es) | Compuestos de disulfuro para el suministro de agentes farmacéuticos | |
KR20220113737A (ko) | 나노물질 | |
CN106068119A (zh) | 用于修饰细胞表面的组合物和方法及使用方法 | |
US20220233668A1 (en) | Glycopeptide vaccine | |
AR119980A1 (es) | Composiciones nematicidas | |
US20110008415A1 (en) | Novel lipophilic compositions and uses thereof | |
JP2017538715A5 (es) | ||
De Lombaerde et al. | Combinatorial Screening of Biscarbamate Ionizable Lipids Identifies a Low Reactogenicity Lipid for Lipid Nanoparticle mRNA Delivery | |
EP3774806A1 (en) | Tlr7 and / or tlr8 agonists | |
Svystonyuk et al. | Acellular extracellular matrix SCAFFOLD reprograms cardiac fibroblasts and promotes adaptive cardiac remodeling and repair | |
AR120561A1 (es) | Compuestos terapéuticos | |
Petukhov et al. | The Synthesis and Transfection Activity of Disulfide Polycationic Amphiphiles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |